Market
How will public opinion on McKinsey's role in the opioid crisis change by end of 2025?
1
Resolution / Starting Odds
More Negative • 25%
Remains the Same • 25%
More Positive • 25%
Unchanged • 25%
Public opinion polls and surveys from reputable sources such as Gallup or Pew Research Center
Story
McKinsey Agrees to $650 Million Settlement with DOJ Over Opioid Consulting and Deferred-Prosecution Agreement
Dec 17, 2024, 01:32 PM
Consulting firm McKinsey & Company has agreed to pay $650 million to resolve a Department of Justice (DOJ) investigation regarding its role in advising Purdue Pharma on increasing OxyContin sales. This settlement comes as part of a deferred-prosecution agreement, allowing McKinsey to avoid criminal charges related to its consulting work that contributed to the opioid epidemic. Critics have expressed concern over the leniency of the settlement, highlighting the firm's significant financial gains from its opioid-related consulting, which coincided with a rise in overdose deaths. The DOJ's decision has sparked debate about the accountability of corporations involved in the opioid crisis, particularly in light of McKinsey's past actions and its ongoing relationship with government entities.
View original story
Similar markets
Significantly negative • 25%
Positive • 25%
Neutral • 25%
Moderately negative • 25%
More negative • 25%
Less negative • 25%
Unchanged • 25%
Mixed opinions • 25%
No impact on business operations • 25%
Improvement in business operations • 25%
Significant decline in business operations • 25%
Minor impact on business operations • 25%
U.S. Department of Justice • 25%
Securities and Exchange Commission • 25%
Other • 25%
Federal Trade Commission • 25%
Yes • 50%
No • 50%
No significant change • 25%
Decrease • 25%
Increase • 25%
Uncertain/Other • 25%
No change • 25%
More favorable • 25%
Less favorable • 25%
Uncertain • 25%